Global Health Matters

19 May 2022 - By Janis Bernat
This article featured in the Media Planet Clinical Trials campaign, available online and disseminated in print with the New Scientist. The COVID-19 pandemic has taught us a lot and yet we can still keep learning. While the pandemic has impacted everyone globally in ways that could never have been imagined, ...
Read More
27 April 2022 - By Morgane De Pol
Vaccines are one of the most effective and cost-efficient medical technologies ever developed. Except for clean water, nothing has had a larger effect on global health than vaccines, especially for children.[1] Before COVID-19, even if vaccines saved millions of lives every year, they had become a routine and unremarkable part ...
Read More
25 April 2022 - By James Anderson
This op-ed was originally published for Media Planet's Malaria and Neglected Tropical Diseases campaign on 25 April 2022. We must make up ground lost in the fight against malaria during the COVID-19 pandemic. Innovation in vaccines and treatment offer hope for solutions. From 2019 to 2020, there was a 12.4% ...
Read More
29 March 2022 - By
This article was originally published on Africa Young Innovators for Health Award on 29 March 2022. Marie-Chantal Umunyana joins IFPMA and HYPER‘s virtual discussion on: “The Importance of Diversity & Equal Opportunities in a Healthy R&D Environment – Workplace & Organizational Culture.”  The discussion convened both young and senior leaders to identify and present initiatives ...
Read More
23 March 2022 - By Morgane De Pol
It’s been over two years since the biopharmaceutical industry committed to playing the greatest possible role in the global response to COVID-19 In that time, we have seen how one virus can disrupt all our lives, our daily routines, our education and health systems, our economies, and our world. We ...
Read More
7 March 2022 - By Thomas B. Cueni
This blog was originally published in The Medicine Maker.  Technology transfer partnerships have been the cornerstone in the fight against the COVID-19 pandemic, enabling rapid scaling of health innovations but also raising new challenges. Now, we need long-term, sustainable national policies to ensure tech transfer continues to improve access to ...
Read More
2 March 2022 - By Thomas B. Cueni
This article was originally published on Pharma Boardroom on 2 March 2022. As the focus of the global COVID-19 pandemic response shifts downstream from the development and production of vaccines to vaccination campaigns themselves, IFPMA Director-General Thomas Cueni lays out the biopharmaceutical industry’s three new overarching priorities: supporting country readiness, ...
Read More
27 January 2022 - By Thomas B. Cueni
This piece appeared first on PharmaBoardroom.  Drawing on the findings of a recent report launched under the Business Ethics for APEC SMEs Initiative, Thomas Cueni of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) outlines the benefits for small and medium-sized enterprises (SMEs) of adopting ethical practices. Cueni highlights some of ...
Read More
22 December 2021 - By Thomas B. Cueni
Against the backdrop of increasing concerns around Omicron, last week we convened a media briefing on the biopharmaceutical industry’s efforts over the past year since the first COVID-19 vaccine was administered. This was a unique opportunity to share insights from the Biotechnology Innovation Organization (BIO) and the Developing Countries Vaccine Manufacturers’ ...
Read More
16 December 2021 - By Greg Perry
Innovation is crucial to identifying solutions to Africa’s healthcare needs. However, without the participation of women in the fields of Science, Technology, Engineering, and Mathematics (STEM), Africa and the world is bound to miss their invaluable perspectives and critical contributions. Women account for 30 percent of Sub-Saharan Africa's researchers and ...
Read More
Photo credt: GISAID
16 December 2021 - By Thomas B. Cueni
This op-ed was originally published for Swissinfo on 16 December 2021. Thomas Cueni, Director General of the International Federation of Pharmaceutical Manufacturers and Associations, calls for unrestricted access to pathogen sharing to help the world prepare for new variants and future pandemics. Before the Covid-19 pandemic, only experts knew what ...
Read More
10 December 2021 - By
In this blog, originally published on UHC2030, UHC2030’s Private Sector Constituency shares some examples of how the private sector contributes to strengthening health systems for UHC and health security. At least half the world’s population still lacks access to essential health services, and almost 100 million people are pushed into ...
Read More
9 December 2021 - By James Anderson
This op-ed was originally published for Media Planet Value of Vaccines campaign on 9 December 2021. It is difficult to predict the nature of the next health threat. We do not know where, how or when it will hit. What we know is that playing catch is a lost battle. ...
Read More
1 December 2021 - By Greg Perry
This World AIDS Day, we mark 40 years since the first HIV case was identified. While there is much to reflect on, the most important takeaway is that there is still further to go to prevent new infections and treat the millions of people living with HIV/AIDS today. HIV has ...
Read More
25 November 2021 - By James Anderson
This op-ed was originally published on Pharma Boardroom on 25 November 2021. The World Health Assembly Special Session on a Pandemic Treaty, which will convene health ministries from around the world in Geneva next week, offers a unique opportunity to take a look back and share some important lessons learnt ...
Read More
1 2 3 16